Genetic test could spare thousands from chemotherapy

Doctors could use the test to determine whether or not a patient’s cancer is likely to spread to other parts of the body, which prompts the need for toxic chemotherapy treatment.

An estimated 9,700 patients with certain types of early stage breast cancer would to be offered the test each year, and in a third of cases treatment regimes are likely to be altered as a result.

For those whose outlook is good, this could mean they are spared gruelling rounds of chemotherapy which result in sideeffects including nausea, vomiting, insomnia, hair loss and fatigue.

Read the full, original story here: Genetic test could spare thousands from chemotherapy

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.